Studi In Silico Jatropon, Jatropolon A, Jatropolon B, dan Turunan Sebagai Anti Kanker Terhadap Reseptor Bcl-2
Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ) · 29.12.2025 · 8 (2) · 104-114
DOI: 10.35799/pmj.v8i2.64761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ), online erschienen am 29.12.2025. Verfasst von Ramanda R Syaifullah und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Jatrophone and its congeners jatropholone A and B, have shown potent cytotoxicity by triggering apoptosis through Bcl-2–regulated mechanisms. We evaluated jatrophone, jatropholones A and B and twenty-two related derivatives as Bcl-2–targeting anticancer leads using in silico approaches. Molecular properties and preliminary affinity estimates were obtained with ChemOffice; molecular docking to the Bcl-2 binding site was performed with AutoDock Tools. ADME predictions used PreADMET and toxicity risk assessment applied Toxtree with the Benigni/Bossa rule-base. Twelve compounds violated Lipinski’s rule of five, while thirteen displayed identical amino-acid contacts at the receptor, suggesting a conserved binding mode. Predicted plasma protein binding was high for most derivatives except compounds 20 and 22. Six derivatives were flagged as potentially genotoxic; none were predicted mutagenic. Docking ranked jatropholone A as the top candidate (binding energy −8.67 kcal/mol). These results prioritize jatropholone A for experimental validation as a promising Bcl-2–targeting anticancer agent.
Zitieren
APA
Syaifullah, R. R., Sholeh, M., Azizah, W., Kasman, N. F., Nursamsiar, Paluseri, A., & Lukman (2025). Studi In Silico Jatropon, Jatropolon A, Jatropolon B, dan Turunan Sebagai Anti Kanker Terhadap Reseptor Bcl-2. Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ), 8(2), 104-114. https://doi.org/10.35799/pmj.v8i2.64761
Vancouver
Syaifullah RR, Sholeh M, Azizah W, Kasman NF, Nursamsiar, Paluseri A, et al. Studi In Silico Jatropon, Jatropolon A, Jatropolon B, dan Turunan Sebagai Anti Kanker Terhadap Reseptor Bcl-2. Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ). 2025;8(2):104-114. doi:10.35799/pmj.v8i2.64761
BibTeX
@article{Syaifullah2025,
author = {Syaifullah, Ramanda R and Sholeh, Muhammad and Azizah, Wafiq and Kasman, Nur F and Nursamsiar and Paluseri, Andi and Lukman},
title = {Studi In Silico Jatropon, Jatropolon A, Jatropolon B, dan Turunan Sebagai Anti Kanker Terhadap Reseptor Bcl-2},
journal = {Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ)},
year = {2025},
volume = {8},
number = {2},
pages = {104--114},
doi = {10.35799/pmj.v8i2.64761}
}
EUVIMED